Liraglutide suppresses TNF--induced degradation of extracellular matrix in human chondrocytes: a therapeutic implication in osteoarthritis
Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
The complete landscape of GLP-1 telehealth platforms , independently scored and ranked
[27] demonstrated that GIP receptor neurons differ in their connectivity, transcriptomic profile, peripheral accessibility, and appetite-controlling mechanisms with vast heterogeneity of the central GIP receptor signalling axis and further studies are needed to clarify the effects of GIP pharmacology on feeding behavior
The study found that being older, female, or eating less protein was linked to greater muscle lossbut here's the good news: eating more protein may help protect against this
Proper medication management is crucial to avoid the risks associated with inadequate treatment